Major investors are demanding a boardroom shake-up at Swiss chocolate maker Lindt & Sprüngli following the ouster of CEO Adalbert Lechner. The company faces a 25% share price drop in 2026 and downward revisions to its sales guidance due to aggressive pricing strategies. Investors are now questioning the long-standing control of Chairman Ernst Tanner.
The leadership crisis at Lindt & Sprüngli has entered a new phase, with institutional investors calling for a structural overhaul of the company's board. The demand follows the October 2026 departure of CEO Adalbert Lechner, which occurred after the chocolate maker was forced to issue two consecutive sales warnings. While the company has installed former CEO Dieter Weisskopf as an interim leader, shareholders argue that this move is insufficient to address the deep-seated governance and strategic issues affecting the firm.
The current unrest is rooted in a financial performance decline, with the stock price falling approximately 25% year-to-date in 2026. The company’s troubles trace back to an aggressive pricing strategy aimed at offsetting high commodity costs. After raising prices by 19% in 2025 and an additional 12% during the first half of 2026, consumer demand faltered. This resistance from customers has forced the company to slash its organic sales growth outlook to between 0% and 2%, a significant departure from its historical performance.
Governance Concerns Take Center Stage
Beyond immediate financial results, the primary friction point between management and shareholders is board independence. Chairman Ernst Tanner has led the company for 32 years, and investors are now scrutinizing the board’s composition. Critics point out that only three of the eight current board members meet standard independence criteria. Furthermore, pension funds associated with the Chairman’s office reportedly hold significant voting influence, which activists claim limits the board’s ability to provide objective oversight.
The challenge for the company is twofold. It must navigate a complex consumer market while also managing external pressures. There is growing debate among analysts regarding the impact of GLP-1 weight-loss medications on the confectionery sector. While some market participants fear these drugs could permanently reduce the appetite for premium chocolate, the company has historically reported resilience among its consumer base.
Looking ahead, the firm is attempting to regain stability while maintaining a medium-term growth target of 6% to 8%. However, the internal conflict between legacy leadership and shareholders may complicate these efforts. Investors and analysts will be closely watching the search for a permanent CEO, any further changes to board composition, and, most importantly, whether the company can recover sales volumes without further disrupting its pricing strategy.